UK's NICE to release coronary DES review determination in late December:
This article was originally published in Clinica
The UK's National Institute for Health and Clinical Excellence (NICE) is expected to issue its final appraisal document (FAD) on the use in the NHS of coronary drug-eluting stents in late December, Clinica has learnt from sources involved in the appraisal. The process was delayed to enable consultees to consider additional information related to the economic analysis used by NICE in assessing the cost-effectiveness of using DESs to treat coronary artery disease. NICE recommended against using the technology in all but a very small proportion of cases.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.